Specialty Health Portals with Universal Appeal
Therapeutic Communities take healthcare marketing to a whole new level by relaying your message via a trusted, comprehensive specialty health portal owned and operated by an independent third party, Therapeutic Marketing.
Traditionally, online promotional programs target a particular audience in a specific disease state. Therapeutic Communities, however, focus on developing complete web properties that connect, inform and educate a variety of professional and consumer audiences with a common interest in a single therapeutic category. Providing news, resources and community important to all involved throughout the continuum of care enables us to unite in our universal effort – to provide better treatment pathways and cures for patients and families living with a particular illness.
This Therapeutic Community will deliver the latest in bone and joint science, technology and industry news, a comprehensive social network and valuable resources all geared toward this vast market segment.
This Therapeutic Community will focus on everything cardio, and will feature daily news headlines, professional and consumer social networks, and valuable information from the American College of Cardiology, the American Heart Association and other professional and public resources.
This online community will give healthcare professionals the up-to-the-minute news, intelligence, analysis and insight necessary to successfully run their businesses and practices, and treat the 80 million Americans who have diabetes or prediabetes. And it will deliver reliable information to patients, family members and friends living with or at risk for diabetes.
Everything about cancer and tumors, from physical, chemical and biological attributes to preventive care and treatment modalities, will be available at this Therapeutic Community. Professionals and consumers alike can search the latest news, research developments and other resources, or network and share information conveniently in one online location.